Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bartlett NL, Rosenberg SA and Hoppe RT (1995) Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. J Clin Oncol 13: 1080–1088
Canellos GP, Anderson JR and Propert KJ (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. New Engl J Med 327: 1478–1484
Cullen MH, Stuart NS and Woodroffe C (1994) ChIVPP/PABIOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group. J Clin Oncol 12: 779–787
Diehl V, Franklin J and Hasenclever D (1998) BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 16: 3810–3821
Diehl V, Franklin J and Sieber M (2000) Dose escalated BEACOPP chemotherapy improves failure free survival in advanced Hodgkin's disease: updated results of the German Hodgkin's Lymphoma Study Group. Blood 96: 576a
Hancock BW, Gregory WM and Cullen MH (2001) ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: Results of a British National Lymphoma Investigation/Central Lymphoma Group randomised controlled trial. British Journal of Cancer,
Hasenclever D and Diehl V (1998) A prognostic score for advanced Hodgkin's disease. New Engl J Med 339: 1506–1514
Horning SJ, Hoppe RT and Breslin S (1998) Brief chemotherapy (CT) (Stanford V) and involved field radiotherapy (RT) are highly effective for advanced Hodgkin disease's (HD). Proc Am Soc Clin Oncol 17: 16a
Lazarus HM, Rowlings PA and Zhang M-J (1999) Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 17: 534–545
Linch DC, Winfield D and Goldstone AH (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 341: 1051–1054
Radford JA, Crowther D and Rohatiner AZS (1995) Results of a randomised trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease. J Clin Oncol 13: 2379–2385
Sweetenham JW, Proctor SJ and Blaise D (1997) High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Bone Marrow Transplantation 20: 745–752
Yuen AR, Rosenberg SA and Hoppe RT (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood 89: 814–822
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sweetenham, J. Trials in advanced Hodgkin's disease: asking the right questions at the right time. Br J Cancer 84, 1291–1292 (2001). https://doi.org/10.1054/bjoc.2001.1840
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.1840
